Who We Are
CBE is a division of the UCSF Office of Research under the Executive Vice Chancellor and Provost. CBE advises the UCSF student- and fellow-led entrepreneur group, the Innovation Accelerator.
CBE Staff
Gail Schechter, Ph.D.
CBE Director
Gail.Schechter@ucsf.edu
415/514-9670
Message From the Director (application/pdf, 42.4 kB, info)
CBE Program Analyst
cbe@research.ucsf.edu
415/514-9672
Instructors
Robert Blum, EVP,
Cytokinetics
G. Steven Burrill, CEO,
Burrill &
Company
Charles Craik, UCSF Professor
Cynthia Kenyon, UCSF Professor
Barry Kramer,
Partner, Fenwick & West, LLP
Lynn Pasahow,
Partner, Fenwick & West, LLP
James Sabry, CEO,
Cytokinetics
Michael
Shuster,
Fenwick &
West LLP
Brian Shoichet,
UCSF Professor
David Sretavan, UCSF Professor
Guest Lecturers
Leslie Benet, UC San Francisco
Larry Blaszczak, Eli Lilly Corporation
D. Benjamin Borson, Borson Law Group, PC
Nicola Campbell, Soffinova Ventures
Pete Carroll, Medlen & Carroll, LLP
Rowan Chapman, Mohr Davidow Ventures
Farah Champsi, Alta Partners
Leon Chen, KAI Pharmaceuticals
Sam Colella, Versant Ventures
Pamela Contag, President, Xenogen
John Cornwell, Life Science Angels
Thomas J. Dietz, Pacific Growth Equities
Fred Dorey, Cooley Godward, LLP
Ted Driscoll, Sand Hill Angels
Mark Edwards, Recombinant Capital
Thomas Fogarty, Stanford University
David Green, Project Impact
Ann Hanham, Burill & Company
Jose Haresco, Merriman Curhan Ford & Co
David Haselwood, Burrill & Company
James Henderson, UCSF Office of Technology Management
Russell Hirsch, Prospect Venture Partners
Jerry Iwata, Comerica Bank
Rusty Johnson, W.R. Hambrecht
Andrew Kramer, Apneon
Michael Lauffer, Mach Ventures
Tracy Lefteroff, PricewaterhouseCoopers
Nancy M. Lynch, Scale Venture Partners
Bernard Lo, UC San Francisco
Teri Melese, UCSF School of Medicine
George Milstein, Pacific Growth Equities
Curtis Mo, WilmerHale, LLP
Geoff Parker, Managing Director, Goldman Sachs
Ngoc-Ha Nguyen, UCSF Office of Technology Management
Michael Powel, Sofinnova Ventures
Sunita Rajdev, UCSF Office of Technology Management
Kinkead Reiling, Amyris Biotechnologies
Christina Ring, Sunesis
Pete Roddy, CFO Pain Therapeutics
Cynthia Robbins-Roth
Sandra Ruggles, Catalyst Biosciences
James Sabry, Cytokinetics
Samuel Saks, Jazz Pharmaceuticals
Randy Scott, Genomic Health
Michael Shuster, Fenwick & West LLP
Barry Selick, Sofinnova Ventures
David Spellmeyer, Nodality
Lewis T. "Rusty" Williams, Chairman, FivePrime Therapeutics
Garrett Vygantas, Burrill & Company
Gregg Wurster, Burrill & Company
Zack Scott, Burrill & Company
Other Contributors
Kristina Burow, Arch Ventures
Rowan Chapman, Mohr Davidow Ventures
David Charron, UC Berkeley Lester Center
Anirban (Rana) Datta, UCSF Postdoctoral Fellow
Michael Finney, Angel Investor
Doug Fisher, New Leaf Ventures
Paul Grand, RCT Ventures
Karl Handelsman, CMEA Ventures
David Haselwood, Burrill & Co.
Jason Lettman, Split Rock Partners
Nancy Lynch, Scale Venture Partners
Felice Lu, Canaan Partners
Peter Mui
Antoun Nabhan, Sagamore BioVentures
Tim Nolan
Jessica Owens, Kleiner Perkins
Micah Siegel, Concept2Company
Adam Tomasi, Alta Partners
Gregg Wurster
Katherine T. Moortgat, Mohr, Davidow Ventures
Partners
UCSF Innovation Accelerator
UCSF Office of Technology
Management
UCSF Career Center
QB3 Institute
There are no comments.